💊 US FDA approvals galore; An end for many partnerships; Thinking about India’s Union budget
Welcome to February 2022.
Today’s issue is brought to you by AI + ML. Or is it?Â
Keep reading with a 7-day free trial
Subscribe to The Kable to keep reading this post and get 7 days of free access to the full post archives.